Measuring productivity changes in economic evaluation: Setting the research agenda

PharmacoEconomics

Volumn 23, Issue 1, 2005, Pages 47-54

  Koopmanschap, Marc ^a   Burdorf, Alex ^a   Jacob, Karin ^b   Meerding, Willem Jan ^a   Brouwer, Werner ^a   Severens, Hans ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ANKYLOSING SPONDYLITIS; BACKACHE; CARDIOVASCULAR DISEASE; DISABILITY; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SERVICES RESEARCH; HUMAN; MEASUREMENT; NECK PAIN; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW;

ABSENTEEISM; DELIVERY OF HEALTH CARE; EFFICIENCY; HEALTH CARE COSTS; HUMANS; MODELS, ECONOMIC; QUALITY OF LIFE; RESEARCH;

EID: 13244262880     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200523010-00004     Document Type: Review

References (29)

1. Ten years of working conditions in the European Union. Dublin: European Foundation, 2001
2. Brouwer WBF, Schut FT. Priority care for employees: a blessing in disguise? Health Econ 1999 Feb; 8(1): 65-73
3. Guidelines for economic evaluation of pharmaceuticals. 2nd ed. Ottawa (ON): Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 1997
4. Guidelines for the pharmaceutical industry on preparation of submission to the pharmaceutical Benefits Advisory Committee. Canberra: Commonwealth Department of Human Services, 1995
5. Riteco JA, De Heij LJM, van Luijn JCF, et al. Dutch guidelines: pharmacoeconomic research guidelines. Amstelveen: CvZ, 1999
6. Johanneson M, Meltzer D. Some reflections on cost-effectiveness analysis. Health Econ 1998 Feb; 7 (1): 1-7
7. Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ 1995; 15: 171-89
8. Koopmanschap MA, van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med 1992; 34 (9): 1005-10
9. Borghouts JAJ, Koes BW, Vondeling H, et al. Cost-of-illness of neck pain in The Netherlands in 1996. Pain 1999; 80: 629-36
10. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000; 84: 95-103
11. Boonen A, van der Heijde D, Landewe R, et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002; 61: 429-37
12. Gold MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996
13. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs measurement through QOL? A response to the recommendation of the Washington panel. Health Econ 1997; 6: 253-9
14. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ 1997; 6: 511-4
15. Pauly MV, Nicholson S, Xu J, et al. A general model of the impact of absenteeism on employers and employees. Health Econ 2002; 11: 221-31
16. Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Drummond MF, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press, 2001
17. Severens JL, Laheij RJF, Jansen JBMJ, et al. Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther 1998; 12: 919-23
18. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs before and after absence from work: as important as common? Health Policy 2002; 61: 173-87
19. Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity losses without absence: measurement validation and empirical evidence. Health Policy 1999; 48: 13-27
20. Van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labour and health status in economic evaluation of health care: the health and labour questionnaire. Int J Technol Assess Health Care 1996; 12: 405-15
21. Hagberg M, Wigaeus-Tornqvist E, Toomingas A. Self-report reduced productivity due to musculoskeletal symptoms: associations with workplace and individual factors among white-collar computer users. J Occup Rehabil 2002; 12: 151-62
22. Brouwer WBF, Koopmanschap MA. How to calculate indirect costs in economic evaluations. Pharmacoeconomics 1998; 13 (5 Pt 1): 563-9
23. Berger ML, Murray JF, Xu J, et al. Alternative valuations of work loss and productivity. J Occup Environ Med 2001; 43 (1): 18-24
24. Severens JL, Mulder J, Laheij RJF, et al. Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands. Soc Sci Med 2000; 51: 243-9
25. Severens JL, Mulder J, Laheij RJF, et al. Validity of measuring compensation mechanisms for absence from work as a basis for calculating productivity costs. 15th Annual International Society of Technology Assessment in Healthcare (ISTAHC) Meeting; June 1999, Edinburgh
26. Koopmanschap MA, Rutten FFH, van Ineveld BM, et al. Reply to Johannesson's and Karlsson's comment. J Health Econ 1997; 16: 257-9
27. Lamers LM, Meerding WY, Severen JL et al. The relationship between productivity and health related QOL: a empirical exploration in persons with low back pain. QOL Research. In press
28. Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 1992; 2: 67-76
29. Lerner D, Amick BC, Rogers WH, et al. The work limitations questionnaire. Med Care 2001; 39 (1): 72-85